Results 151 to 160 of about 187,553 (368)

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis

open access: yesBritish Journal of Haematology, EarlyView.
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan   +2 more
wiley   +1 more source

The stages in standardizing erythropoietin preparations

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
Preparations of recombinant human erythropoietin (rhEPO) are included in the list of vital and essential drugs for medical use. When evaluating the quality of EPO preparations during the manufacturing process, under the state marketing authorization and ...
A. K. Yakovlev   +7 more
doaj  

Comparison of early reactions of the blood system in rats to immobilization, the action of hypoxia and the administration of erythopoietin [PDF]

open access: yes
Three series of experiments were simultaneously carried on rats with the purpose of studying the action of different stimulants on the blood system; rats were subjected to immobilization, hypoxic hypoxia and erythropoietin administration.
Belousova, O. I.   +3 more
core   +1 more source

The Effect of Erythropoietin on Hematopoietic Organs of the Polycythemic Mouse [PDF]

open access: bronze, 1966
Kazuwa Nakao   +3 more
openalex   +1 more source

Design and Evaluation of Eb4Mab‐7‐mG2a: A Dual‐Action Anti‐EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy

open access: yesCancer Science, EarlyView.
Eb4Mab‐7‐mG2a, an anti‐EphB4 monoclonal antibody, significantly suppressed tumor growth in the MCF‐7 xenograft model. Tumor volume and weight were markedly reduced in treated mice, demonstrating its antitumor efficacy against EphB4‐positive breast cancer.
Tomokazu Ohishi   +8 more
wiley   +1 more source

Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To individually evaluate the cardiovascular safety of low‐ and high‐affinity cardiac mitochondrial ATP‐sensitive potassium (mitoKATP) channel sulfonylureas by comparing each to dipeptidyl peptidase‐4 inhibitors (DPP‐4i), a generally cardiovascular‐neutral comparator, given prior evidence suggesting greater cardiovascular risk with high ...
Mei‐Hsiu Chen   +8 more
wiley   +1 more source

Use of a computer model in the understanding of erythropoietic control mechanisms [PDF]

open access: yes
During an eight-week visit approximately 200 simulations using the computer model for the regulation of erythopoiesis were carries out in four general areas: with the human model simulating hypoxia and dehydration, evaluation of the simulation of ...
Dunn, C. D. R.
core   +1 more source

Home - About - Disclaimer - Privacy